These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20026762)

  • 1. Going out on a LIM and cysteine-rich domains 1 limb: a new way to block calcineurin activity.
    Zhang J; Erikson JM; Lindsey ML
    Hypertension; 2010 Feb; 55(2):231-2. PubMed ID: 20026762
    [No Abstract]   [Full Text] [Related]  

  • 2. LIM and cysteine-rich domains 1 regulates cardiac hypertrophy by targeting calcineurin/nuclear factor of activated T cells signaling.
    Bian ZY; Huang H; Jiang H; Shen DF; Yan L; Zhu LH; Wang L; Cao F; Liu C; Tang QZ; Li H
    Hypertension; 2010 Feb; 55(2):257-63. PubMed ID: 20026769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cysteine-rich LIM domains inhibit DNA binding by the associated homeodomain in Isl-1.
    Sánchez-García I; Osada H; Forster A; Rabbitts TH
    EMBO J; 1993 Nov; 12(11):4243-50. PubMed ID: 7901000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcineurin--the missing link in cardiac hypertrophy.
    Izumo S; Aoki H
    Nat Med; 1998 Jun; 4(6):661-2. PubMed ID: 9623967
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypertrophy of the heart: calcineurin-NFAT pathway may be a new therapeutic target].
    Zhang YJ; Dong LF; Wang YL
    Yao Xue Xue Bao; 2006 Oct; 41(10):913-6. PubMed ID: 17184105
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition.
    Lim HW; De Windt LJ; Mante J; Kimball TR; Witt SA; Sussman MA; Molkentin JD
    J Mol Cell Cardiol; 2000 Apr; 32(4):697-709. PubMed ID: 10756124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT.
    Crabtree GR
    Cell; 1999 Mar; 96(5):611-4. PubMed ID: 10089876
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of the LIM domains in DNA recognition by the Lhx3 neuroendocrine transcription factor.
    Bridwell JA; Price JR; Parker GE; McCutchan Schiller A; Sloop KW; Rhodes SJ
    Gene; 2001 Oct; 277(1-2):239-50. PubMed ID: 11602361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcineurin independent development of myocardial hypertrophy in transgenic rats overexpressing the mouse renin gene, TGR(mREN2)27.
    Diedrichs H; Mei C; Frank KF; Boelck B; Schwinger RH
    J Mol Med (Berl); 2004 Oct; 82(10):688-95. PubMed ID: 15322704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of the LIM-domain-binding factor Ldb1 with LIM homeodomain proteins.
    Agulnick AD; Taira M; Breen JJ; Tanaka T; Dawid IB; Westphal H
    Nature; 1996 Nov; 384(6606):270-2. PubMed ID: 8918878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcineurin inhibitors and cardiac hypertrophy.
    Force T; Rosenzweig A; Choukroun G; Hajjar R
    Lancet; 1999 Apr; 353(9161):1290-2. PubMed ID: 10218524
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcineurin and beyond: cardiac hypertrophic signaling.
    Molkentin JD
    Circ Res; 2000 Oct; 87(9):731-8. PubMed ID: 11055975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac hypertrophy: sorting out the circuitry.
    McKinsey TA; Olson EN
    Curr Opin Genet Dev; 1999 Jun; 9(3):267-74. PubMed ID: 10377279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcineurin enhances MAPK phosphatase-1 expression and p38 MAPK inactivation in cardiac myocytes.
    Lim HW; New L; Han J; Molkentin JD
    J Biol Chem; 2001 May; 276(19):15913-9. PubMed ID: 11279073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LIM domain proteins.
    Dawid IB; Toyama R; Taira M
    C R Acad Sci III; 1995 Mar; 318(3):295-306. PubMed ID: 7788499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure.
    De Windt LJ; Lim HW; Taigen T; Wencker D; Condorelli G; Dorn GW; Kitsis RN; Molkentin JD
    Circ Res; 2000 Feb; 86(3):255-63. PubMed ID: 10679475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LIM and cysteine-rich domains 1 (LMCD1) regulates skeletal muscle hypertrophy, calcium handling, and force.
    Ferreira DMS; Cheng AJ; Agudelo LZ; Cervenka I; Chaillou T; Correia JC; Porsmyr-Palmertz M; Izadi M; Hansson A; Martínez-Redondo V; Valente-Silva P; Pettersson-Klein AT; Estall JL; Robinson MM; Nair KS; Lanner JT; Ruas JL
    Skelet Muscle; 2019 Oct; 9(1):26. PubMed ID: 31666122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a LIM domain-containing gene in the Cyathostominae.
    Matthews JB; Johnson DR; Lazari O; Craig R; Matthews KR
    Vet Parasitol; 2008 Jun; 154(1-2):82-93. PubMed ID: 18406533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ssdp proteins bind to LIM-interacting co-factors and regulate the activity of LIM-homeodomain protein complexes in vivo.
    van Meyel DJ; Thomas JB; Agulnick AD
    Development; 2003 May; 130(9):1915-25. PubMed ID: 12642495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The progress in complex homeobox domains].
    Zhou SX; Sun X; Lu ZH
    Yi Chuan; 2004 Nov; 26(6):984-90. PubMed ID: 15640136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.